Cargando…
Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathway
Dysfunction or death of pancreatic β cells underlies both types of diabetes. This functional decline begins with β cell stress and de-differentiation. Current drugs for type 2 diabetes (T2D) lower blood glucose levels but they do not directly alleviate β cell stress nor prevent, let alone reverse, β...
Autores principales: | Blum, Barak, Roose, Adam N, Barrandon, Ornella, Maehr, René, Arvanites, Anthony C, Davidow, Lance S, Davis, Jeffrey C, Peterson, Quinn P, Rubin, Lee L, Melton, Douglas A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204634/ https://www.ncbi.nlm.nih.gov/pubmed/25233132 http://dx.doi.org/10.7554/eLife.02809 |
Ejemplares similares
-
Synthetic modified Fezf2 mRNA (modRNA) with concurrent small molecule SIRT1 inhibition enhances refinement of cortical subcerebral/corticospinal neuron identity from mouse embryonic stem cells
por: Sadegh, Cameron, et al.
Publicado: (2021) -
Implementation of a Drug Screening Platform to TargetGch1 Expression in Injured Mouse Dorsal Root Ganglion Neurons
por: Cronin, Shane J. F., et al.
Publicado: (2023) -
Editorial: TGF-β in Human Disease: Friend or Foe?
por: Zheng, Guoping, et al.
Publicado: (2021) -
Tgfβ signaling is critical for maintenance of the tendon cell fate
por: Tan, Guak-Kim, et al.
Publicado: (2020) -
The Roles of TGF-β Signaling in Cerebrovascular Diseases
por: Zhang, Yizhe, et al.
Publicado: (2020)